Wellcome is a global charitable foundation supporting scientists and researchers and Fiona, who is Oxford University Statutory Professor in the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences and Director of the Kennedy Institute of Rheumatology, is thrilled to be joining.
"Through funding great scientific ideas, Wellcome is committed to promoting health around the world. It will be an honour to help deliver this goal," she said.
Fiona has extensive experience across the research environment – she has chaired the European Research Council Advanced Grants panel, is a member of the Royal Society Premier Awards Committee and co-chairs Wellcome’s Science Interview Panel.
Her pioneering research in immunology has provided crucial insights into the causes of chronic intestinal inflammation and possible treatments. She was the Sidney Truelove Professor of Gastroenterology and Head of the Translational Gastroenterology Unit at Oxford from 2009-14. Her particular interest is translating basic research into clinical applications.
She is a Fellow of the Royal Society, the European Molecular Biology Organisation (EMBO) and the Academy of Medical Sciences.
In the next five years, Wellcome aims to spend up to £5 billion helping thousands of people all over the world explore ideas in science, population health, medical innovation, the humanities and social sciences and public engagement. This support will address some of the world’s biggest challenges such as how to be better prepared for the next major epidemic.
Fiona will formally join Wellcome’s Board of Governors in January 2018.